Studies have shown that down-regulation of PRDX1 significantly inhibits the growth rate of BC cells, and in vivo, PRDX1-deficient MCF-7 cells exhibit delayed tumor growth upon transplantation (46). Here, PRDX1 is linked to breast cancer.